SYT1-Associated Neurodevelopmental Disorder: A Narrative Review.
Edith Riggs, Zaynab Shakkour, Christopher L Anderson...
https://pubmed.ncbi.nlm.nih.gov/36291375Actively Recruiting
Led by University of Missouri-Columbia · Updated on 2026-06-03
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting a prospective, longitudinal natural history study to understand the clinical progression of children and adults with Synaptotagmin1-Associated Neurodevelopmental Disorder, also known as Baker Gordon Syndrome (BAGOS). The study aims to develop effective outcome measures and diagnostic tools to prepare for future clinical trials, focusing on demographic, genetic, environmental factors, treatments, and medications linked to the disorder's development and outcomes. Participants will undergo various assessments including standard scales and questionnaires to evaluate global development, language, memory, and motor functions. They will keep sleep and seizure diaries, provide a small blood sample for whole genome sequencing and proteomic analysis, and have brain imaging via MRI and electroencephalography (EEG) to identify disease biomarkers. A small skin sample will be collected to develop patient-specific stem cells for further research on the impact of Synaptotagmin1 mutations. During the 24-month study, participants and their caregivers will be assessed using neurological and disability evaluation scales, behavior assessments, and other developmental tests. Researchers will collect medical data, monitor motor milestones, and evaluate sleep and attention. Caregivers and legal representatives will also participate by completing questionnaires and consenting to study procedures. The goal is to enhance understanding of BAGOS and prepare the healthcare system for future treatments.
CONDITIONS
Baker Gordon Syndrome Natural History Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial visit
Participants undergo brain MRI, EEG recordings, blood collection for whole genome sequencing and proteomic analysis, and a skin punch biopsy to collect samples for research and biomarker identification.
1 visit (in-person)
Duration - 24 months
Participants are assessed over time using standard scales and questionnaires related to development, behavior, motor function, and sleep, while medical data is collected retrospectively and prospectively to understand the natural history of Baker Gordon Syndrome.
Multiple visits over 24 months
Total: 1 location
1
University of Missouri Columbia
Columbia, Missouri, United States, 65201
Actively Recruiting
W
W. David R Arnold, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Edith Riggs, Zaynab Shakkour, Christopher L Anderson...
https://pubmed.ncbi.nlm.nih.gov/36291375